Skip to main content

Together we are beating cancer

Donate now

Research and trials

Showing 12 out of 1680 results
A corridor of computer servers

To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities.  To get the most out of data-driven programmes we need to see some changes in the UK’s health data infrastructure. Here we explore what those changes need to be, and how programmes like CD3 can align with government’s priorities. 

by Ben Jones | Analysis | 19 March 2025

19 March 2025

This entry is part 23 of 23 in the series That Cancer Conversation
The DETERMINE trial team celebrating at the Bionow awards

Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements. Since launching in December 2021, the DETERMINE trial has hit many milestones on the way to providing much needed treatment options for people with rare cancers, including treating its 100th patient. On Rare Disease Day, we look back at some of those key achievements.

by Tim Bodicoat | In depth | 28 February 2025

28 February 2025

A green beam of light from a radiotherapy machine.

Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story. Modern radiotherapy is used to treat more than 140,000 people with cancer in the UK every year. We've brought it a long way since 1896. Here's the full story.

by Tim Gunn | In depth | 17 February 2025

17 February 2025

Salmonella bacteria (rod-shaped organisms coloured blue) in a bowel cancer tumour (coloured beige). The bacteria looks like it is rushing into a hole in the tumour tissue.

Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once. Our researchers are modifying Salmonella bacteria into a treatment that can work with the immune system to attack bowel cancer from two sides at once.

by Tim Gunn, Fiona MacLeod | News | 23 January 2025

23 January 2025

Data centre filled with rows of servers

Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk. Today, Cancer Research UK, the National Institute for Health and Care Research (NIHR) and the Engineering and Physical Sciences Research Council (EPSRC) are announcing £10 million to create the Cancer Data-Driven Detection programme, which aims to use data to identify individual cancer risk.

by Amy Warnock, Graeme Sneddon | News | 22 January 2025

22 January 2025

Two Cancer Research UK researchers working at a lab bench.

We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach. We look back on how more than 10-years of mission-based funding has transformed the UK lung cancer research ecosystem and what our new mission focused government can learn from our approach.

by Nick Jones | Analysis | 13 January 2025

13 January 2025